The FDA announced the approval of darolutamide for treating metastatic castration-sensitive prostate cancer. This review was conducted under Project Orbis, which allows for concurrent submission and review...
The 2025 American Society of Clinical Oncology guideline update redefines the role of sentinel lymph node biopsy (SLNB) in early-stage breast cancer. Building on evidence from major trials, the update...
Secretary Robert F. Kennedy Jr. announced that the CDC will no longer recommend the COVID-19 booster vaccine for healthy children and pregnant people. The announcement comes despite previous CDC...
Whether in the form of unnecessary tests, inappropriate referrals, or overuse of costly treatments, waste continues to erode value, strain resources, and impede patient-centered care.
The FDA has announced that it will limit access to COVID-19 vaccines, making them only available to high-risk populations. The organization also announced that they will require manufacturers to further...
A system-wide reduction in default opioid prescriptions modestly decreased opioid dispensing but increased refill rates, highlighting ongoing disparities in postoperative pain management, according to the...
New research explores long COVID risks in children, ACIP's expanded RSV vaccine use, U.S. disease resurgence under falling immunization, and long COVID’s burden on health care workers.
A 2-year follow-up of the COVAXID trial shows that repeated SARS-CoV-2 mRNA booster doses significantly improve antibody and T cell responses in immunocompromised patients, even among initial poor...
A population-based cohort study found that receiving two or more doses of a COVID-19 vaccine was associated with a significantly lower risk of developing persistent post–COVID condition among individuals...
